Search

Your search keyword '"Ait‐Arsa, Imade"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Ait‐Arsa, Imade" Remove constraint Author: "Ait‐Arsa, Imade"
28 results on '"Ait‐Arsa, Imade"'

Search Results

4. Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode

5. Supplemental Figure S5 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells

6. Supplementary Methods from Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

7. Data from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells

8. Supplemental Figure Legends from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells

9. Supplementary Figures 1-4 from Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

10. Supplemental Methods from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells

13. RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis

14. Caffeic Acid, One of the Major Phenolic Acids of the Medicinal Plant Antirhea borbonica, Reduces Renal Tubulointerstitial Fibrosis

17. Synthesis and Automated Labeling of [18F]Darapladib, a Lp-PLA2 Ligand, as Potential PET Imaging Tool of Atherosclerosis

21. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.

22. Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells

23. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53

24. Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

25. Abstract B245: Claudin-1 (CLDN1) as a new therapeutic target in colorectal cancer: Inhibition of cell growth and survival by an anti-CLDN1 monoclonal antibody.

26. Abstract 1639: Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma

27. Synthesis and Automated Labeling of [ 18 F]Darapladib, a Lp-PLA 2 Ligand, as Potential PET Imaging Tool of Atherosclerosis.

28. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.

Catalog

Books, media, physical & digital resources